Mostrar registro simples

dc.contributor.authorColpani, Verônicapt_BR
dc.contributor.authorKowalski, Sérgio Candidopt_BR
dc.contributor.authorStein, Airton Tetelbompt_BR
dc.contributor.authorBuehler, Anna Mariapt_BR
dc.contributor.authorZanetti, Danielpt_BR
dc.contributor.authorCôrtes, Gabrielpt_BR
dc.contributor.authorMelo Junior, Edison Vieira dept_BR
dc.contributor.authorEbeidalla, Jorgiany Emerickpt_BR
dc.contributor.authorOliveira, Natiela Beatriz dept_BR
dc.contributor.authorGuerra, Renata Leboratopt_BR
dc.contributor.authorSilva, Sarah Nascimentopt_BR
dc.contributor.authorDuncan, Bruce Bartholowpt_BR
dc.contributor.authorFalavigna, Maiconpt_BR
dc.contributor.authorSchünemann, Holger J.pt_BR
dc.date.accessioned2021-07-06T04:46:05Zpt_BR
dc.date.issued2020pt_BR
dc.identifier.issn1478-4505pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/223231pt_BR
dc.description.abstractIn Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critical analysis and define future steps in PG development in Brazil, we carried out a structured assessment of strengths, weaknesses, opportunities and threats (SWOT analysis) for the development of a national guideline programme. Participants consisted of academia, methodologists, medical societies and healthcare system representatives. In summary, the PG development process has improved in Brazil and current investments in methodological research and capacity-building are ongoing. Despite the centralised processes for public PGs, standardised procedures for their development are not well established and human resources are insufficient in number and capacity to develop the amount of trustworthy documents needed. Brazil’s capacity could be strengthened and initial efforts have been made such as the adoption of standards proposed by world-renowned institutions in PG development and enhancement of the involvement of key stakeholders. Further steps involve the alignment between health technology assessment and PG processes for synergy and the development of a national network to promote the interaction between groups involved in the development of PGs. The lessons learned from this paper could be used to foster debate on guideline development, especially for countries facing similar threats on this topic.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofHealth research policy and systems. London. Vol. 18 (2020), 69, 6 p.pt_BR
dc.rightsOpen Accessen
dc.subjectProtocolos clínicospt_BR
dc.subjectGuideline developmenten
dc.subjectEvidence-based medicineen
dc.subjectMedicina baseada em evidênciaspt_BR
dc.subjectBrazilen
dc.subjectPrática clínica baseada em evidênciaspt_BR
dc.subjectGuia de prática clínicapt_BR
dc.subjectClinical practiceen
dc.subjectBrasilpt_BR
dc.titleClinical practice guidelines in Brazil : developing a national programmept_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001126917pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples